Liposomal Drug Delivery. Advantages and Limitations from a Clinical Pharmacokinetic and Therapeutic Perspective

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1991 Sep 1

PMID 1764868

Citations 23

Authors

R M Fielding

Affiliations

Soon will be listed here.

Citing Articles

Improving dexamethasone drug loading and efficacy in treating rheumatoid arthritis via liposome: Focusing on inflammation and molecular mechanisms.

Zamanian M, Zafari H, Osminina M, Skakodub A, Aboqader Al-Aouadi R, Golmohammadi M Animal Model Exp Med. 2024; 8(1):5-19.

PMID: 39627850 PMC: 11798740. DOI: 10.1002/ame2.12518.

Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles.

Neaz S, Alam M, Imran A Heliyon. 2024; 10(21):e39917.

PMID: 39553547 PMC: 11567044. DOI: 10.1016/j.heliyon.2024.e39917.

A Comprehensive Review of the Strategies to Reduce Retinoid-Induced Skin Irritation in Topical Formulation.

Narsa A, Suhandi C, Afidika J, Ghaliya S, Elamin K, Wathoni N Dermatol Res Pract. 2024; 2024:5551774.

PMID: 39184919 PMC: 11344648. DOI: 10.1155/2024/5551774.

Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies.

Zembala J, Forma A, Zembala R, Januszewski J, Zembala P, Adamowicz D J Clin Med. 2023; 12(18).

PMID: 37762739 PMC: 10531576. DOI: 10.3390/jcm12185798.

Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors.

Ferreira M, Aguiar S, Bettencourt A, Gaspar M Drug Deliv Transl Res. 2020; 11(1):72-85.

PMID: 32514703 DOI: 10.1007/s13346-020-00791-8.

References

Ahmad I, Sarkar A, BACHHAWAT B . Liposomal amphotericin-B in the control of experimental aspergillosis in mice: Part I--Relative therapeutic efficacy of free and liposomal amphotericin-B. Indian J Biochem Biophys. 1989; 26(6):351-6. View

Bally M, Nayar R, Masin D, Hope M, Cullis P, Mayer L . Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta. 1990; 1023(1):133-9. DOI: 10.1016/0005-2736(90)90018-j. View

Bonte F, Juliano R . Interactions of liposomes with serum proteins. Chem Phys Lipids. 1986; 40(2-4):359-72. DOI: 10.1016/0009-3084(86)90079-4. View

Lichtenberg D, Barenholz Y . Liposomes: preparation, characterization, and preservation. Methods Biochem Anal. 1988; 33:337-462. DOI: 10.1002/9780470110546.ch7. View

Saba T . Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med. 1970; 126(6):1031-52. View

Sanders S, Buchi K, Goddard M, Lang J, Tolman K . Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers. Antimicrob Agents Chemother. 1991; 35(6):1029-34. PMC: 284281. DOI: 10.1128/AAC.35.6.1029. View

Cho M, Scieszka J, Cramer C, Thompson D, Vidmar T . Neutrophil-mediated transport of liposomes across the Madin Darby canine kidney epithelial cell monolayer. Pharm Res. 1989; 6(1):78-84. DOI: 10.1023/a:1015859921397. View

Gabizon A, Price D, Huberty J, Bresalier R, Papahadjopoulos D . Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res. 1990; 50(19):6371-8. View

Ellens H, Rustum Y, Mayhew E, Ledesma E . Distribution and metabolism of lipsome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues. J Pharmacol Exp Ther. 1982; 222(2):324-30. View

10.

Ellens H, Mayhew E, Rustum Y . Reversible depression of the reticuloendothelial system by liposomes. Biochim Biophys Acta. 1982; 714(3):479-85. DOI: 10.1016/0304-4165(82)90157-x. View

11.

Kim S, Kim D, Geyer M, Howell S . Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy. Cancer Res. 1987; 47(15):3935-7. View

12.

Delgado G, Potkul R, Treat J, Lewandowski G, Barter J, Forst D . A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. Am J Obstet Gynecol. 1989; 160(4):812-7; discussion 817-9. DOI: 10.1016/0002-9378(89)90296-2. View

13.

Patterson T, Andriole V . The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur J Cancer Clin Oncol. 1989; 25 Suppl 2:S63-8. View

14.

Presant C, Proffitt R, Turner A, Williams L, WINSOR D, Werner J . Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer. 1988; 62(5):905-11. DOI: 10.1002/1097-0142(19880901)62:5<905::aid-cncr2820620509>3.0.co;2-3. View

15.

Bard D, Knight C, Page-Thomas D . Effect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbits. Clin Exp Rheumatol. 1985; 3(3):237-42. View

16.

Roerdink F, Regts J, van Leeuwen B, Scherphof G . Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. Biochim Biophys Acta. 1984; 770(2):195-202. DOI: 10.1016/0005-2736(84)90130-5. View

17.

Abra R, Hunt C, Lau D . Liposome disposition in vivo. VI: Delivery to the lung. J Pharm Sci. 1984; 73(2):203-6. DOI: 10.1002/jps.2600730214. View

18.

Woodle M, Papahadjopoulos D . Liposome preparation and size characterization. Methods Enzymol. 1989; 171:193-217. DOI: 10.1016/s0076-6879(89)71012-0. View

19.

Ranade V . Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. J Clin Pharmacol. 1989; 29(8):685-94. DOI: 10.1002/j.1552-4604.1989.tb03403.x. View

20.

Taylor K, Taylor G, Kellaway I, Stevens J . The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm Res. 1989; 6(7):633-6. DOI: 10.1023/a:1015917918130. View